Sanofi and GSK signed agreements with the Government of Canada to supply up to 72 million doses of adjuvanted COVID-19 vaccine
On Sept. 22, 2020, Sanofi and GSK announced they had signed agreements with the Government of Canada for…
On Sept. 22, 2020, Sanofi and GSK announced they had signed agreements with the Government of Canada for…
On Sept. 1, 2020, Sanofi announced that the global Phase 3 trial investigating intravenously administered Kevzara (sarilumab) at…
On Aug. 31, 2020, Novavax announced it had reached an agreement in principle with the Government of Canada…
On Aug. 5, 2020, Pfizer Canada and BioNTech announced an agreement with the Government of Canada to supply…
On Aug. 5, 2020, Variation Biotechnologies, an Ottawa-based subsidiary of VBI Vaccines, announced that it had been awarded…
On Jul. 22, 2020, through the Canadian COVID Genomics Network (CanCOGeN) ‘a new initiative was launched by Genome…
On Jul. 21, 2020, BD (Becton, Dickinson) announced additional pandemic orders for needles and syringes from the U.S….
On Jun. 30, 2020, AquaBounty Technologies announced it had successfully commenced the commercial-scale harvest of conventional Atlantic salmon…
On Jun. 25, 2020, the Government of Canada announced the results of that funding competition: an investment of…
On May 21, 2020, the BioProducts Institute at the University of British Columbia announced it had designed a…
On May 12, 2020, the National Research Council of Canada (NRC) announced a collaboration with CanSino Biologics to…
On May 12, 2020, the National Research Council of Canada (NRC) and the University of Saskatchewan’s (USask) Vaccine…
On May 6, 2020, Laurent Pharmaceuticals announced that it has obtained the approval from Health Canada to initiate…
On May 3, 2020, AbCellera announced it had received a commitment of up to $175.6 million in support…
On Apr. 27, 2020, Abbott announced that Health Canada authorized use of FreeStyle Libre system, a sensor-based glucose…
On Apr. 27, 2020, Edwards Lifesciences announced that Health Canada approved an expanded indication for use of the…
On Apr. 17, 2020, as part of Project Orbis, the U.S. Food and Drug Administration (FDA) approved Seagen’s…
On Apr. 13, 2020, Bausch Health announced it has initiated a clinical trial program in Canada evaluating an…
On Apr. 9, 2020, James Petrie, a graduate student in applied mathematics at the University of Waterloo in…
On Apr. 6, 2020, 3M and the White House announced a plan to import 166.5 million respirators over…
On Mar. 31, 2020, VBI Vaccines announced a collaboration with the National Research Council of Canada (NRC) to…
On Mar. 25, 2020, University of Oxford researchers announced they had launched the world’s first COVID-19 government response…
On Mar. 25, 2020, Quidel received CE Mark for the Lyra SARS-CoV-2 assay, authorizing Quidel to market and…
On Mar. 6, 2020, the Government of Canada announced an investment of nearly $27 million to fund Coronavirus…
On Dec. 11, 2019, Seqirus announced that its cell-based quadrivalent influenza vaccine (QIVc) had received approval from Health…
On Aug. 1, 2019 the Siteman Cancer Center announced it was awarded a six-year, $7.8 million grant from…
On Jan. 30, 2019, the Government of Canada announced an investment of $18 million over five years in…
On Jan. 29, 2019, Ontario Institute for Cancer Research’s (OICR) Drug Discovery Program’s first-of-its-kind leukemia therapy discovery received…
On Nov. 13, 2018, Canadian Prime Minister Justin Trudeau announced federal funding for the Institute for Advanced Medical…
On May 24, 2018, the United States Food and Drug Administration (U.S. FDA) released a statement on GR2E…